Neuralink’s current trial, named the The PRIME Study, is aimed at providing individuals with quadriplegia the ability to control external devices with their thoughts. Experts in the field say that the ...
Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results